Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Merta

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
Folia Biologica|March 3, 2007
The influence of three endothelin-1 polymorphisms on the progression of IgA nephropathyD Maixnerová, M Merta, J Reiterová, et al.
Kidney & Blood Pressure Research|December 9, 2008
Influence of VEGF polymorphism on progression of autosomal dominant polycystic kidney diseaseJ Reiterová, H Obeidová, M Lenícek, et al.
Sbornik Lekarsky|April 12, 2003
[Kidney involvement in light-chain deposition disease]M Merta, R Rysavá, J Zabka, et al.
Sbornik Lekarsky|February 8, 2002
[Optimal therapy with erythropoietin (EPO) in patients with renal anemia on hemodialysis therapy]M Merta, D Sobotová, J Zahálková, et al.
Sbornik Lekarsky|April 12, 2003
[Renal infiltration in lymphoma--diagnosis in renal biopsy (case report)]M Merta, E Jelínková, J Zabka, et al.
Casopis Lekaru Ceskych|October 18, 1995
[The effect of pefloxacin on nephrotic syndrome in experimental adriamycin nephropathy]T Zima, V Tesar, I Rychlík, et al.
Sbornik Lekarsky|October 1, 1991
[Hypertension in patients with polycystic kidneys--the effect of volume expansion]J Zabka, V Tesar, M Merta, et al.
Casopis Lekaru Ceskych|July 3, 1998
[Interleukin-6, tumor necrosis factor alpha and their soluble receptors in Bence-Jones nephropathy. Possible role in pathogenesis andthe importance in the determination of prognosis in renal insufficiency]I Spicka, Z Masek, M Jirsa, et al.
Casopis Lekaru Ceskych|November 24, 1999
[Plasma leptin levels in patients with kidney diseases of various etiologies]V Chábová, V Tesar, J Perusicová, et al.
Sbornik Lekarsky|January 1, 1996
[Clinical problems in kidney disorders associated with myeloma and other paraproteinemias]M Merta, I Spicka, R Rysavá, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Folia Biologica|March 3, 2007
The influence of three endothelin-1 polymorphisms on the progression of IgA nephropathyD Maixnerová, M Merta, J Reiterová, et al.
Kidney & Blood Pressure Research|December 9, 2008
Influence of VEGF polymorphism on progression of autosomal dominant polycystic kidney diseaseJ Reiterová, H Obeidová, M Lenícek, et al.
Sbornik Lekarsky|April 12, 2003
[Kidney involvement in light-chain deposition disease]M Merta, R Rysavá, J Zabka, et al.
Sbornik Lekarsky|February 8, 2002
[Optimal therapy with erythropoietin (EPO) in patients with renal anemia on hemodialysis therapy]M Merta, D Sobotová, J Zahálková, et al.
Sbornik Lekarsky|April 12, 2003
[Renal infiltration in lymphoma--diagnosis in renal biopsy (case report)]M Merta, E Jelínková, J Zabka, et al.
Casopis Lekaru Ceskych|October 18, 1995
[The effect of pefloxacin on nephrotic syndrome in experimental adriamycin nephropathy]T Zima, V Tesar, I Rychlík, et al.
Sbornik Lekarsky|October 1, 1991
[Hypertension in patients with polycystic kidneys--the effect of volume expansion]J Zabka, V Tesar, M Merta, et al.
Casopis Lekaru Ceskych|July 3, 1998
[Interleukin-6, tumor necrosis factor alpha and their soluble receptors in Bence-Jones nephropathy. Possible role in pathogenesis andthe importance in the determination of prognosis in renal insufficiency]I Spicka, Z Masek, M Jirsa, et al.
Casopis Lekaru Ceskych|November 24, 1999
[Plasma leptin levels in patients with kidney diseases of various etiologies]V Chábová, V Tesar, J Perusicová, et al.
Sbornik Lekarsky|January 1, 1996
[Clinical problems in kidney disorders associated with myeloma and other paraproteinemias]M Merta, I Spicka, R Rysavá, et al.
Pageof 10